SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001328143-18-000005
Filing Date
2018-11-01
Accepted
2018-11-01 16:02:30
Documents
56
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q adms10q09302018.htm 10-Q 1025135
2 EXHIBIT 10.1 admsq310q2018ex101.htm EX-10.1 17336
3 EXHIBIT 10.2 admsq310q2018ex102.htm EX-10.2 273041
4 EXHIBIT 31.1 admsq310q2018ex311.htm EX-31.1 14295
5 EXHIBIT 31.2 admsq310q2018ex312.htm EX-31.2 14407
6 EXHIBIT 32 admsq310q2018ex321.htm EX-32 9285
13 admslogo01.jpg GRAPHIC 11399
  Complete submission text file 0001328143-18-000005.txt   4297674

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT adms-20180930.xml EX-101.INS 727337
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adms-20180930.xsd EX-101.SCH 30055
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adms-20180930_cal.xml EX-101.CAL 54984
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adms-20180930_def.xml EX-101.DEF 129771
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adms-20180930_lab.xml EX-101.LAB 392062
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adms-20180930_pre.xml EX-101.PRE 218045
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36399 | Film No.: 181153638
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1